T1	PROC 46 63	Estudio de fase 2
T2	CHEM 67 73	BA3011
T3	PROC 77 88	monoterapia
#1	AnnotatorNotes T3	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T4	CHEM 110 119	nivolumab
#2	AnnotatorNotes T4	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	LIVB 123 140	pacientes adultos
T6	Age 133 140	adultos
T7	DISO 145 188	cáncer de pulmón no microcítico metastásico
#3	AnnotatorNotes T7	C4744562; Metastatic Lung Non-Small Cell Carcinoma; Neoplastic Process
T8	Neg_cue 162 164	no
T9	Negated 165 176	microcítico
T10	PROC 211 228	Estudio de fase 2
T11	CHEM 263 281	mecbotamab vedotin
T12	CHEM 283 289	BA3011
T13	PROC 294 305	monoterapia
#4	AnnotatorNotes T13	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T14	CHEM 327 336	nivolumab
#5	AnnotatorNotes T14	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T15	LIVB 340 357	pacientes adultos
T16	Age 350 357	adultos
T17	DISO 362 405	cáncer de pulmón no microcítico metastásico
#6	AnnotatorNotes T17	C4744562; Metastatic Lung Non-Small Cell Carcinoma; Neoplastic Process
T18	Neg_cue 379 381	no
T19	Negated 382 393	microcítico
T20	DISO 427 454	progresión de la enfermedad
#7	AnnotatorNotes T20	C0242656; Disease Progression; Pathologic Function
T21	PROC 466 477	tratamiento
#8	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	CHEM 521 524	ALK
T23	DISO 527 539	intolerancia
T24	PROC 548 559	tratamiento
#9	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	DISO 583 599	Cáncer de pulmón
#10	AnnotatorNotes T25	C0242379; Malignant neoplasm of lung; Neoplastic Process | C0684249; Carcinoma of lung; Neoplastic Process
T26	DISO 626 677	Cáncer de pulmón de células no pequeñas metastásico
T27	Neg_cue 654 656	no
T28	Negated 657 665	pequeñas
T29	LIVB 708 717	pacientes
#11	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	DISO 737 768	cáncer de pulmón no microcítico
#12	AnnotatorNotes T30	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T31	Neg_cue 754 756	no
T32	Negated 757 768	microcítico
T33	DISO 770 774	CPNM
#13	AnnotatorNotes T33	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T34	DISO 812 823	metastásico
#14	AnnotatorNotes T34	C4255448; Metastasis; Pathologic Function
T35	Age 877 885	≥18 años
T36	PHYS 897 910	Función renal
#15	AnnotatorNotes T36	C0232804; Renal function; Organ or Tissue Function
T37	PHYS 923 939	Función hepática
T38	PHYS 952 972	Función hematológica
T39	Duration 1108 1124	al menos 3 meses
T40	DISO 1154 1165	Cardiopatía
#16	AnnotatorNotes T40	C0018799; Heart Diseases; Disease or Syndrome
T41	DISO 1209 1219	metástasis
#17	AnnotatorNotes T41	C0027627; Neoplasm Metastasis; Neoplastic Process | C2939419; Secondary Neoplasm; Neoplastic Process
T42	ANAT 1240 1264	sistema nervioso central
#18	AnnotatorNotes T42	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T43	ANAT 1266 1269	SNC
#19	AnnotatorNotes T43	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T44	PROC 1274 1285	Tratamiento
#20	AnnotatorNotes T44	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T45	CHEM 1300 1326	derivado de la auristatina
T46	CHEM 1405 1410	vinca
T47	DISO 1430 1450	reacciones alérgicas
#21	AnnotatorNotes T47	C0020517; Hypersensitivity; Pathologic Function | C1527304; Allergic Reaction; Pathologic Function
T48	PROC 1466 1477	tratamiento
#22	AnnotatorNotes T48	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T49	CHEM 1482 1485	AcM
#23	AnnotatorNotes T49	C0003250; Monoclonal Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T50	Spec_cue 1508 1516	sospecha
T51	DISO 1520 1527	alergia
#24	AnnotatorNotes T51	C0020517; Hypersensitivity; Pathologic Function
T52	Speculated 1520 1527	alergia
T53	DISO 1530 1542	intolerancia
T54	Speculated 1530 1542	intolerancia
T55	CHEM 1563 1575	medicamentos
#25	AnnotatorNotes T55	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0304228; Proprietary drug, NOS; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T56	PROC 1644 1673	intervención de cirugía mayor
T57	Duration 1694 1707	las 4 semanas
T58	PROC 1732 1746	administración
#26	AnnotatorNotes T58	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T59	CHEM 1750 1756	BA3011
T60	PROC 1800 1848	pruebas del virus de la inmunodeficiencia humana
T61	LIVB 1850 1853	VIH
#27	AnnotatorNotes T61	C0458074; Human immunodeficiency virus (HIV) status; Finding
T62	DISO 1870 1897	inmunodeficiencia adquirida
#28	AnnotatorNotes T62	C0001175; Acquired Immunodeficiency Syndrome; Disease or Syndrome
T63	DISO 1899 1903	sida
#29	AnnotatorNotes T63	C0001175; Acquired Immunodeficiency Syndrome; Disease or Syndrome
T64	PROC 234 259	evaluar la administración
T65	CHEM 511 515	EGFR
T66	CHEM 485 506	inhibidor del PD-1/L1
T67	LIVB 1908 1927	Mujeres embarazadas
T68	Date 1933 1953	período de lactancia
T69	PROC 1583 1596	administrarán
T70	PROC 836 847	histológica
T71	PROC 852 867	citológicamente
T72	PHYS 1944 1953	lactancia
T73	Quantifier_or_Qualifier 776 795	localmente avanzado
T74	Observation 798 809	irresecable
T75	Observation 897 919	Función renal adecuada
T76	Quantifier_or_Qualifier 940 948	adecuada
T77	Observation 952 981	Función hematológica adecuada
T78	CONC 1023 1057	Eastern Cooperative Oncology Group
T79	CONC 1059 1063	ECOG
T80	Result_or_Value 1068 1073	0 o 1
T81	CONC 1087 1104	esperanza de vida
T82	Quantifier_or_Qualifier 1166 1192	clínicamente significative
T83	CONC 1224 1233	controlar
T84	Quantifier_or_Qualifier 1328 1337	conjugado
T85	CONC 1344 1352	conjugar
T86	Quantifier_or_Qualifier 1454 1462	grado ≥3
T87	Result_or_Value 1776 1796	resultados positivos
T88	Patient 123 140	pacientes adultos
T89	Patient 340 357	pacientes adultos
T90	History_of 527 539	intolerancia
T91	Patient 708 717	pacientes
T92	History_of 1274 1285	Tratamiento
T93	History_of 1300 1326	derivado de la auristatina
T94	History_of 1430 1450	reacciones alérgicas
T95	History_of 1520 1527	alergia
T96	History_of 1530 1542	intolerancia
T97	History_of 1644 1673	intervención de cirugía mayor
T98	History_of 1812 1848	virus de la inmunodeficiencia humana
T99	History_of 1850 1853	VIH
T100	History_of 1870 1897	inmunodeficiencia adquirida
T101	History_of 1899 1903	sida
T102	Patient 1908 1953	Mujeres embarazadas o en período de lactancia
